AbobotulinumtoxinA (Espad Pharmed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AbobotulinumtoxinA (Espad Pharmed), covering 2025-05-07 to 2025-05-07. Get the full timeline:
Most recent: Clinical Trial Update: A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines [Phase 3]